Clinical Trial Update: Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated botulinum toxin type A versus placebo for bilateral blepharospasm. The trial assessed efficacy and safety, and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharospasm

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Bilateral Blepharospasm (BEB) | Phase 3 | Status: COMPLETED | Results posted: 2018-03-01